RPSG Ventures buys Clarionix for INR 0.01 cr in 2026

Deal snapshot: a small ticket entry into healthcare

RPSG Ventures Limited has acquired 100% equity shareholding of Clarionix Healthcare Private Limited for a purchase consideration of INR 0.01 crore (INR 1 lakh). The acquisition became effective on June 25, 2026, making Clarionix a wholly-owned subsidiary of RPSG Ventures. Clarionix was incorporated recently on May 20, 2026, and has nil turnover at present. The stated objective of the acquisition is to explore new business opportunities in the medical sector.

The transaction involved the acquisition of 10,000 equity shares of face value INR 10 each, representing the entire equity share capital of Clarionix. RPSG Ventures also disclosed that the acquisition does not fall within related party transactions. It added that no specific governmental or regulatory approvals were required for completing the acquisition.

Who is Clarionix Healthcare and what it is set up to do

Clarionix Healthcare Private Limited has been set up to undertake healthcare-related businesses. As described in the company’s disclosures, this includes establishing and managing medical care facilities. The exchange filing also referenced operations such as hospitals, nursing homes, blood banks, and other medical facilities as part of the contemplated healthcare scope.

Because Clarionix is newly incorporated and has nil turnover, the acquisition is less about acquiring an operating asset and more about creating a corporate vehicle for the healthcare business. That context becomes important given the larger restructuring plan approved alongside the acquisition.

The larger move: Woodlands hospital business to be housed in Clarionix

Along with the Clarionix acquisition, RPSG Ventures’ board approved a composite scheme of arrangement among RPSG Ventures Limited, Woodlands Multispeciality Hospital Limited (WMHL), and Clarionix Healthcare Private Limited. Under the scheme, WMHL is proposed to be amalgamated with RPSG Ventures. Subsequently, Woodlands would be dissolved.

The scheme also provides for the transfer of the Hospital and Nursing Undertaking from RPSG Ventures to Clarionix on a slump sale basis. The consideration for this slump sale has been set at INR 400 crore (also described as INR 4 billion). The company noted that the composite scheme is subject to regulatory approvals.

RPSG Ventures said executing the restructuring through a single scheme is intended to ensure continuity of hospital licences, registrations, and contracts, without disruption to operations. The filing positioned the move as a way to bring the healthcare business under a listed platform, improve access to capital for future expansion, provide dedicated management focus to the hospital business, ring-fence healthcare operations from other businesses, and create flexibility to induct strategic or financial investors at the subsidiary level.

Merger mechanics: preference shares, conversion and redemption terms

As part of the amalgamation of Woodlands into RPSG Ventures, the company will issue 500 optionally convertible redeemable preference shares (OCRPS) for every one equity share held in Woodlands Multispeciality. Post-merger, every 500 preference shares will be converted into five equity shares of RPSG Ventures within 18 months of allotment of preference shares.

The company also disclosed that after the 18-month deadline, the preference shares will carry a 6% per annum coupon and be redeemed at par after 6.5 years. The preference shares will not be listed on stock exchanges.

In addition, the company stated that the shareholding pattern of RPSG Ventures will remain unchanged immediately upon the scheme becoming effective. However, it added that if all OCRPS are converted into equity shares, the post-scheme shareholding pattern would reflect promoters holding 68.91% and non-promoters holding 31.09% of the total expanded equity capital of 50,799,909 shares.

Key facts table

Market reaction: stock ended higher on the day

Following the disclosure, RPSG Ventures’ shares ended at INR 889.75 on the National Stock Exchange, up 3.7% from the previous close, as per the filing. The move coincided with the board’s approvals for the acquisition and the composite scheme.

The disclosures also included historical market references, including a cited closing price of INR 876.65 as of June 17, 2026, and a stated market capitalisation of INR 2,900.48 crore at that time. Another price point of INR 299 per share was mentioned as a “current market price” on the date of publishing that report, separate from the exchange-filing day reference.

Rainbow Investments disclosure: shareholding and encumbrance statement

Separately, Rainbow Investments Limited disclosed that it held 1,29,29,326 equity shares in RPSG Ventures Limited as of March 31, 2026. It confirmed that it did not create any encumbrance on these shares, directly or indirectly, during the financial year ended March 31, 2026, under applicable SEBI regulations.

Context: RPSG Ventures’ broader portfolio and earlier deals

RPSG Ventures Limited, formerly known as CESC Ventures Limited, is part of the RP-Sanjiv Goenka Group. The company’s disclosures referenced its activity across multiple areas, including information technology related services to the power generation and distribution business of CESC and its subsidiaries.

Through subsidiaries, the group operates in FMCG categories such as packaged snacks (including “Too Yumm” and “Evita”), personal care (Naturali and Within Beauty), and Ayurveda or modern pharma (Dr. Vaidya’s and 360). The material also referenced RPSG Capital Ventures as a consumer-focused venture capital fund investing in the D2C ecosystem.

On the deal front, the provided information noted that on Nov 19, 2025, RPSG Ventures acquired 50,740 shares (40%) in FSP Design, making it an associate, with an earlier reference to acquiring 40% at an enterprise value of INR 455.17 crore and an option for an additional 10%. It also included an earlier disclosure that RPSG Ventures acquired 51% shareholding in RPSG Sports Venture Private Limited, pursuant to a share purchase agreement dated Aug 30, 2022.

Why this restructuring matters: clearer ring-fencing and capital flexibility

The core of the announcement is not the INR 0.01 crore consideration for Clarionix, but the structure RPSG Ventures is putting in place for the healthcare business. By moving the Hospital and Nursing Undertaking into a wholly-owned subsidiary via a slump sale, the group is creating a dedicated platform for healthcare operations within its listed structure.

The company’s filing explicitly linked this to continuity of licences and contracts, management focus, and flexibility to bring in strategic or financial investors at the subsidiary level. These points are operational and structural rather than projections, but they explain why the board paired the Clarionix acquisition with the composite scheme on the same day.

Conclusion: approvals next, with execution tied to the scheme

RPSG Ventures has completed the acquisition of Clarionix Healthcare effective June 25, 2026, and has board approval in place for a composite scheme involving Woodlands Multispeciality Hospital and the transfer of hospital operations into Clarionix for INR 400 crore. The scheme is subject to regulatory approvals, and the next major milestones will depend on clearances and the scheme becoming effective as outlined in the company’s filings.